InvestorsHub Logo
Followers 19
Posts 6050
Boards Moderated 3
Alias Born 05/23/2019

Re: ANIA77 post# 52758

Tuesday, 07/23/2019 11:00:05 AM

Tuesday, July 23, 2019 11:00:05 AM

Post# of 82995
This is what I found positive for CVSI. CVSI will rebound once the weaks sell off and those that see an opportunity will add to their positions or Curaleaf sellers will come aboard, imo

Here is what was included in the letter and why The FDA has hinted to GRAS. Also CVS will most likely take Curaleaf products off their shelves, and this is too a positive for CVSI products located in those stores. Imo Wolf


Your “CBD Lotion,” “CBD Pain-Relief Patch,” “CBD Tincture,” and “CBD Disposable Vape Pen” products

are not generally recognized as safe and effective

for the above referenced uses and, therefore, the products are “new drugs” under section 201(p) of the FD&C Act, 21 U.S.C. 321(p). New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA, as described in sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a). FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective.

+++++++++++++++++++++++++++++++++++++

CVS Distribution of CBD Products Sends Curaleaf Shares Soaring
By Craig Giammona
March 20, 2019, 5:33 PM EDT
Updated on March 21, 2019, 9:41 AM EDT

Curaleaf announced the agreement during an earnings conference call on Wednesday. The company’s CBD products will be available in about 800 stores to start, Curaleaf said on the call, and hopes to expand to more.

https://www.bloomberg.com/news/articles/2019-03-20/cvs-joins-cannabis-derived-wellness-trend-selling-cbd-products
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News